Rapid Influenza Diagnostic Test (RIDT) Market Report – Research, Industry Analysis Reports and Market Demands

Global Rapid Influenza Diagnostic Test (RIDT) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Rapid Influenza Diagnostic Test (RIDT) Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Immunochromatography
- 1.3.3 Colloidal Gold Method
- 1.3.4 Others
1.4 Market Analysis by Sample Type
- 1.4.1 Overview: Global Rapid Influenza Diagnostic Test (RIDT) Consumption Value by Sample Type: 2021 Versus 2025 Versus 2032
- 1.4.2 Nasal Swab
- 1.4.3 Throat Swab
- 1.4.4 Nasopharyngeal Swab
- 1.4.5 Others
1.5 Market Analysis by Antigen Target
- 1.5.1 Overview: Global Rapid Influenza Diagnostic Test (RIDT) Consumption Value by Antigen Target: 2021 Versus 2025 Versus 2032
- 1.5.2 Influenza A Antigen
- 1.5.3 Influenza B Antigen
- 1.5.4 Influenza A/B Antigen
- 1.5.5 Others
1.6 Market Analysis by Testing Scenario
- 1.6.1 Overview: Global Rapid Influenza Diagnostic Test (RIDT) Consumption Value by Testing Scenario: 2021 Versus 2025 Versus 2032
- 1.6.2 Laboratory-Based Test Kits
- 1.6.3 Point-of-Care Test (POCT) Kits
- 1.6.4 Home-Use Self-Testing Kits
- 1.6.5 Others
1.7 Market Analysis by Application
- 1.7.1 Overview: Global Rapid Influenza Diagnostic Test (RIDT) Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.7.2 Hospital
- 1.7.3 Clinics
- 1.7.4 Home
- 1.7.5 Others
1.8 Global Rapid Influenza Diagnostic Test (RIDT) Market Size & Forecast
- 1.8.1 Global Rapid Influenza Diagnostic Test (RIDT) Consumption Value (2021 & 2025 & 2032)
- 1.8.2 Global Rapid Influenza Diagnostic Test (RIDT) Sales Quantity (2021-2032)
- 1.8.3 Global Rapid Influenza Diagnostic Test (RIDT) Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Rapid Influenza Diagnostic Test (RIDT) by Manufacturer

3.1 Global Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Manufacturer (2021-2026)
3.2 Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Manufacturer (2021-2026)
3.3 Global Rapid Influenza Diagnostic Test (RIDT) Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Rapid Influenza Diagnostic Test (RIDT) by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Rapid Influenza Diagnostic Test (RIDT) Manufacturer Market Share in 2025
- 3.4.3 Top 6 Rapid Influenza Diagnostic Test (RIDT) Manufacturer Market Share in 2025
3.5 Rapid Influenza Diagnostic Test (RIDT) Market: Overall Company Footprint Analysis
- 3.5.1 Rapid Influenza Diagnostic Test (RIDT) Market: Region Footprint
- 3.5.2 Rapid Influenza Diagnostic Test (RIDT) Market: Company Product Type Footprint
- 3.5.3 Rapid Influenza Diagnostic Test (RIDT) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region
- 4.1.1 Global Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Region (2021-2032)
- 4.1.2 Global Rapid Influenza Diagnostic Test (RIDT) Consumption Value by Region (2021-2032)
- 4.1.3 Global Rapid Influenza Diagnostic Test (RIDT) Average Price by Region (2021-2032)
4.2 North America Rapid Influenza Diagnostic Test (RIDT) Consumption Value (2021-2032)
4.3 Europe Rapid Influenza Diagnostic Test (RIDT) Consumption Value (2021-2032)
4.4 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Consumption Value (2021-2032)
4.5 South America Rapid Influenza Diagnostic Test (RIDT) Consumption Value (2021-2032)
4.6 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Type (2021-2032)
5.2 Global Rapid Influenza Diagnostic Test (RIDT) Consumption Value by Type (2021-2032)
5.3 Global Rapid Influenza Diagnostic Test (RIDT) Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Application (2021-2032)
6.2 Global Rapid Influenza Diagnostic Test (RIDT) Consumption Value by Application (2021-2032)
6.3 Global Rapid Influenza Diagnostic Test (RIDT) Average Price by Application (2021-2032)

7 North America

7.1 North America Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Type (2021-2032)
7.2 North America Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Application (2021-2032)
7.3 North America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country
- 7.3.1 North America Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Country (2021-2032)
- 7.3.2 North America Rapid Influenza Diagnostic Test (RIDT) Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Type (2021-2032)
8.2 Europe Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Application (2021-2032)
8.3 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size by Country
- 8.3.1 Europe Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Rapid Influenza Diagnostic Test (RIDT) Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size by Region
- 9.3.1 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Type (2021-2032)
10.2 South America Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Application (2021-2032)
10.3 South America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country
- 10.3.1 South America Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Country (2021-2032)
- 10.3.2 South America Rapid Influenza Diagnostic Test (RIDT) Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size by Country
- 11.3.1 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Rapid Influenza Diagnostic Test (RIDT) Market Drivers
12.2 Rapid Influenza Diagnostic Test (RIDT) Market Restraints
12.3 Rapid Influenza Diagnostic Test (RIDT) Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Rapid Influenza Diagnostic Test (RIDT) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rapid Influenza Diagnostic Test (RIDT)
13.3 Rapid Influenza Diagnostic Test (RIDT) Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Rapid Influenza Diagnostic Test (RIDT) Typical Distributors
14.3 Rapid Influenza Diagnostic Test (RIDT) Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Rapid Influenza Diagnostic Test (RIDT) market size was valued at US$ 1283 million in 2025 and is forecast to a readjusted size of US$ 2019 million by 2032 with a CAGR of 6.8% during review period.
Rapid Influenza Diagnostic Tests (RIDTs) are in vitro diagnostic products based on immunochromatographic or immunofluorescence technology, designed to qualitatively detect the presence of Influenza A and B nucleoprotein antigens in respiratory specimens within 30 minutes. Product formats mainly include lateral-flow cassette tests, fluorescent immunoassay cartridges, and multiplex panels (e.g., Flu A/B + SARS-CoV-2). Upstream materials primarily consist of monoclonal and polyclonal antibodies, antigen controls, nitrocellulose membranes, plastic housings, and buffer reagents, supplied by specialized reagent and medical consumable manufacturers. Downstream clients include hospital laboratories, community clinics, pharmacies and OTC retailers, public health agencies, and home-testing users.
Based on due-diligence estimates, the global RIDT market in 2024 had an installed production capacity of approximately 320 million units, with sales of around 256 million units. The average selling price was about USD 4.5 per unit, and the average gross margin was approximately 67%. The market continues to grow steadily, driven by recurring flu seasons, enhanced epidemic surveillance, and rising demand for rapid self-testing. With the adoption of multiplex combo tests (e.g., Flu/COVID/RSV) and more sensitive fluorescent immunoassay platforms, the industry is expected to experience further consolidation and technological upgrading.
At present, the global Rapid Influenza Diagnostic Test (RIDT) market is experiencing steady expansion. Frequent mutations in influenza virus strains and the predictable recurrence of seasonal flu outbreaks have increased the demand for rapid testing among public health systems and medical institutions worldwide. RIDTs are gaining wider adoption across hospitals, community clinics, and home-testing scenarios. Since the COVID-19 pandemic, public awareness and acceptance of respiratory virus rapid testing have grown substantially, further driving RIDT utilization. In addition, regulatory authorities in several countries have relaxed approval processes for over-the-counter (OTC) diagnostic products, enabling faster penetration of home-use testing kits.
Looking ahead, the RIDT market is expected to evolve toward multiplex detection and higher sensitivity. With technological advancements, more manufacturers are integrating influenza testing with other respiratory pathogens such as COVID-19, RSV, and adenovirus, allowing “one-sample, multi-target” diagnostics. The integration of digital connectivity will enable real-time data transmission and improve epidemic surveillance efficiency. Meanwhile, emerging Asian markets—supported by large populations and improving primary healthcare infrastructure—are anticipated to become the main growth drivers for global RIDT demand.
Nevertheless, several challenges remain. RIDTs still show lower sensitivity and specificity compared with molecular diagnostic methods such as RT-PCR, leading to potential false negatives in some cases. Price fluctuations in raw materials, high supplier concentration, and varying regulatory standards across regions can increase operational risks and cost pressures for manufacturers. Additionally, rising product homogeneity intensifies market competition, making it difficult for smaller players to achieve economies of scale. Going forward, industry growth will increasingly depend on continuous technological innovation, product diversification, and robust compliance in quality management and regulatory frameworks.
This report is a detailed and comprehensive analysis for global Rapid Influenza Diagnostic Test (RIDT) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Rapid Influenza Diagnostic Test (RIDT) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Rapid Influenza Diagnostic Test (RIDT) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Rapid Influenza Diagnostic Test (RIDT) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Rapid Influenza Diagnostic Test (RIDT) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rapid Influenza Diagnostic Test (RIDT)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rapid Influenza Diagnostic Test (RIDT) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbott, Quidel, Actim, Denka, Roche, Thermo Fisher Scientific, Meridian Bioscience, Sekisui Diagnostics, Princeton BioMeditech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Rapid Influenza Diagnostic Test (RIDT) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Immunochromatography
Colloidal Gold Method
Others
Market segment by Sample Type
Nasal Swab
Throat Swab
Nasopharyngeal Swab
Others
Market segment by Antigen Target
Influenza A Antigen
Influenza B Antigen
Influenza A/B Antigen
Others
Market segment by Testing Scenario
Laboratory-Based Test Kits
Point-of-Care Test (POCT) Kits
Home-Use Self-Testing Kits
Others
Market segment by Application
Hospital
Clinics
Home
Others
Major players covered
BD
Abbott
Quidel
Actim
Denka
Roche
Thermo Fisher Scientific
Meridian Bioscience
Sekisui Diagnostics
Princeton BioMeditech
Access Bio
Response Biomedical
Guangzhou Wondfo Biotech
Jiangsu Bioperfectus Technologies
Hangzhou Biotest Biotech
Wantai BioPharm
Daan Gene
Kehua Bio-Engineering
Zhuhai Encode Medical Engineering
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rapid Influenza Diagnostic Test (RIDT) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rapid Influenza Diagnostic Test (RIDT), with price, sales quantity, revenue, and global market share of Rapid Influenza Diagnostic Test (RIDT) from 2021 to 2026.
Chapter 3, the Rapid Influenza Diagnostic Test (RIDT) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rapid Influenza Diagnostic Test (RIDT) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Rapid Influenza Diagnostic Test (RIDT) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rapid Influenza Diagnostic Test (RIDT).
Chapter 14 and 15, to describe Rapid Influenza Diagnostic Test (RIDT) sales channel, distributors, customers, research findings and conclusion.

Buy now